Hybrid fertility and reproductive care firm Kindbody scored a $25 million funding from JPMorgan Chase’s enterprise unit specializing in employer-sponsored healthcare, Morgan Well being.
Dr. Cheryl Pegus, managing director of Morgan Well being Ventures, will be a part of Kindbody’s board of administrators.
WHAT THEY DO
The New York-based firm gives digital and in-person companies, together with egg freezing, contraception care, gynecological care, fertility testing, and digital wellness and training companies.
Kindbody touts itself as a fertility advantages platform for 112 firms, together with Walmart, Lyft and GEICO.
The funds shall be used to scale the provision of its platform.
“The boundaries related to fertility make beginning or rising a household tough for hundreds of thousands of People. Kindbody’s mission to supply a brand new fertility expertise with their very own healthcare professionals and advantages navigation is exclusive. Their give attention to enhancing entry and well being outcomes helps mitigate lots of the longstanding fairness challenges employers and staff face,” Dr. Pegus mentioned in an announcement. “I look ahead to becoming a member of the Kindbody Board and dealing with the management staff to satisfy the well being wants for the communities Kindbody serves.”
MARKET SNAPSHOT
Simply two months in the past, Kindbody scored a whopping $100 million in funding.
In 2021, it raised $62 million in Series C funding, which constructed on a $32 million Series B raise from July 2020.
Final 12 months, the corporate made three acquisitions: genomics firm Phosphorus Labs, a community of fertility clinics referred to as the Vios Fertility Institute and Chicago-based surrogacy company Alternative Reproductive Resources.
Different firms within the fertility house embody fertility testing firm Proov, reproductive advantages supervisor Carrot Fertility and Nodal, a platform permitting surrogates to attach with supposed mother and father after reviewing their guardian profiles.